Displaying 10 out of 2 results

  1. FILE PHOTO: Loxo Oncology CEO Joshua Bilenker and Chief Business Officer Jacob Van Naarden stand fo

    Eli Lilly to put Loxo executives in charge of new cancer research unit

    U.S. drugmaker Eli Lilly and Co said on Thursday it will create a new cancer research division that will be run by top executives from Loxo ...
  2. Logo of Bayer AG is pictured ahead of the the annual results news conference of the German drugmake

    Inside drugmakers' strategy to boost cancer medicines with 'Lazarus effect'

    In the halls of MD Anderson Cancer Center, the drug Vitrakvi is known for having a "Lazarus effect" in some patients because it can reverse ...